Medicure (MCUJF) Gross Profit Growth (3y) (2012 - 2026)
Medicure (MCUJF) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | 0.95% |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -2.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.94% |
| Dec 31, 2025 | -15.55% |
| Sep 30, 2025 | -39.24% |
| Jun 30, 2025 | -26.06% |
| Mar 31, 2025 | -14.57% |
| Sep 30, 2024 | -33.87% |
| Jun 30, 2024 | -4.43% |
| Mar 31, 2024 | 6.75% |
| Dec 31, 2023 | 147.30% |
| Sep 30, 2023 | 18.29% |
| Jun 30, 2023 | 53.30% |
| Mar 31, 2023 | 36.88% |
| Dec 31, 2022 | 263.86% |
| Sep 30, 2022 | 43.38% |
| Jun 30, 2022 | 18.37% |
| Mar 31, 2022 | 3.23% |
| Sep 30, 2021 | 13.30% |
| Jun 30, 2021 | -21.52% |
| Mar 31, 2021 | -17.10% |
| Dec 31, 2020 | -58.41% |